Polifeprosan 20, 3.85% carmustine slow-release wafer in malignant glioma: evidence for role in era of standard adjuvant temozolomide

The Polifeprosan 20 with carmustine (BCNU, bis-chloroethylnitrosourea, Gliadel(®)) polymer implant wafer is a biodegradable compound containing 3.85% carmustine which slowly degrades to release carmustine and protects it from exposure to water with resultant hydrolysis until the time of release. The...

Descripción completa

Detalles Bibliográficos
Autor principal: Kleinberg, Lawrence
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2012
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3484478/
https://www.ncbi.nlm.nih.gov/pubmed/23118709
http://dx.doi.org/10.2147/CE.S23244

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3484478/
https://www.ncbi.nlm.nih.gov/pubmed/23118709
http://dx.doi.org/10.2147/CE.S23244

Ejemplares similares